Article Title [Persian]
زمینه مطالعه: در زخمهای اندام حرکتی اسب، به علت خونرسانی ضعیفتر و سطح پایین اکسیژن خون در بخشهای تحتانی اندام، عدم تعادل فاکتورهای رشد مرتبط با التیام زخم در روند التیام تأثیر منفی میگذارد. پرده آمنیوتیک آسلولار به علت خواص زیستی و مکانیکی خاص، با ایجاد شرایط مناسب روند التیام به عنوان یک داربست برای درمان زخم استفاده میشود.
هدف: این تحقیق به منظور ارزیابی اثر سلول های بنیادی مشتق از چربی کشت داده شده روی پرده آمنیوتیک آسلولار در التیام زخمهای قسمت تحتانی اندام حرکتی اسب، انجام پذیرفت.
روش کار: نمونه چربی از ناحیه قاعده دم اسب در شرایط آسپتیک اخذ و بلافاصله به آزمایشگاه انتقال داده شد. سلولها با استفاده از روش مکانیکی و هضم آنزیمی جداسازی و پاساژ داده شدند و در مرحله بعد روی پرده آمنیوتیک آسلولار کشت داده شدند. سپس پرده آمنیوتیک آسلولار واجد سلول های بنیادی مشتق از چربی به زخمهای تمام ضخامت 3*2 سانتی متری ایجاد شده در ناحیه متاتارس اندام حرکتی به صورت پوشش روی زخم قرار گرفت. زخمها به چهار گروه تقسیم شدند: گروه اول درمان: پرده آمنیوتیک آسلولار واجد سلولهای بنیادی مشتق از چربی، گروه دوم درمان: پرده آمنیوتیک آسلولار، گروه سوم درمان: سولفادیازین، گروه چهارم: شاهد و بدون درمان. تصویربرداری دیجیتال از زخم ها در هر تغییر پانسمان و اخذ نمونههای بیوپسی به منظورارزیابی هیستوپاتولوژی در روزهای 5، 15 و 30 پس از درمان انجام گرفت.
نتایج: در بررسیهای ژئومتری تصاویر زخمها، گروه درمان با پرده آمنیوتیک آسلولار واجد سلول های بنیادی به طور معنیداری در شاخصهای بازسازی بافت پوششی و اندازه و جمع شدگی زخم، در مقایسه با سه گروه دیگر، وضعیت بهتری را نشان داد (0.05>P). در ارزیابیهای میکروسکوپیک، بازسازی بافت پوششی در روز 5 درمان زخم، گروههای درمان با پرده آمنیوتیک آسلولار واجد سلولهای بنیادی و پرده آمنیوتیک آسلولار به تنهایی، به طور معنیداری بیشتر از گروه کنترل بود (0.05>P). میزان فیبروپلازی در روز 15 در دو گروه درمان با پرده آمنیوتیک آسلولار (با و بدون سلول بنیادی مزانشیمی) در مقایسه با گروه درمان با سولفادیازین اختلافی معنیدار را نشان می داد (0.05>P).
نتیجه گیری نهایی: این نتایج نشان دهنده اثرات مثبت استفاده از پرده آمنیوتیک آسلولار برای بهبود کیفیت و سرعت بهبود زخم است. استفاده از پرده آمنیوتیک آسلولار به همراه سلولهای بنیادی مزانشیمی مشتق از چربی نتایج بهتری نشان میدهد.
Skin wound healing is a dynamic and multifaceted process involving a series of procedures including inflammation, re-epithelization, dermal reconstruction, wound contraction, and remodeling (Sinno and Prakash et al., 2013). It is controlled by interacting signals that regulate many of the cellular and molecular proceedings (Gharaee-Kermani and Phan, 2001).
Large animals are considered as an outstanding model for the study of wound healing process (Theoret and Wilmink, 2013). Horses often suffer from traumatic lesion and/or surgical incisions on the distal limbs and these wounds are often contaminated and associated with widespread tissue and skin loss, so the healing often occurs by second intention and this process in the horse is usually associated with scarring and loss of function (Bischofberger et al., 2011; Gomez et al., 2004; Dart et al., 2002). Second intention contains two independent procedures: 1) contraction, and, 2) re-epithelialization. Second intention is often the only probability to close extensive and profound wounds (Souza et al., 2015; Theoret and Olutoye, 2013). However, this process is slow and may result in the formation of exuberant granulation tissues that is related to delayed closure and increased scar tissue formation on the distal limb (Theoret and Olutoye, 2013; Enoch and Leaper, 2005). Furthermore, in horses, initial inflammatory response is weak and the natural wound debridement procedure is slow, and the risk of infection is high. Therefore, after the initial phase, chronic inflammation at the site of the wound develops and leads to wound infection and also exuberant granulation occurs in most cases. Moreover, equine distal limb wounds recover slowly and usually respond poorly to conventional therapies. Granulation tissues develop more slowly, and wound stays more irregular and purulent for a longer time in horses compared to most animal species (Spaas et al., 2013; Edwards-Milewski et al., 2015; Schwartz et al., 2002; Wilmink et al., 2002; Theoret et al., 2001).
Various cell types, cytokines, chemokines, and extracellular matrix molecules at the wound site interact with many systemic factors like platelets, coagulation cascade, and humoral cell components, which facilitate the wound healing (Soo et al., 2002). Furthermore, many factors such as advanced age, various diseases (e.g., diabetes), and malnutrition can influence the efficiency of the wound healing process (Carter et al., 2003; Singer and Clark, 1999).
An important issue that must be mentioned is wounds below the knee and/or hock are resistant to healing even in the healthiest horses. This issue may be related to poor blood supply and less oxygen to the lower limbs due to the great distance between the trunk and lower limbs which result in imbalance of growth factors (Carter et al., 2003; Theoret et al., 2001; Jorgensen, 2017). This condition may form a hypoxic environment, which can result in up-regulation of pro-fibrotic mediators and exuberant granulation tissue formation that may physically disrupt wound re-epithelialization and contraction (Bischofberger et al., 2015; Dart et al., 2009). Furthermore, after induction of injury, blood supply to the wounded area is decreased due to thrombosis, swelling, and tissue loss. In addition, during second intention healing, the microvasculature is often 50% to 60% obstructed in wounds of the equine distal limb, which delivers the most amount of oxygen and nutrient source. Therefore, the hypoxia reduces wound healing by diminishing the wound’s normal antibacterial response, rate of re-epithelialization, wound contraction, and collagen synthesis (Tracey et al., 2014; Wilmink et al., 2002; Lepault et al., 2005). Chronic non-healing wounds of the lower limb of horses have similarities to human leg ulcers (e.g. humans with diabetic foot ulcers). Therefore, effective therapy of non-healing wounds, acceleration of wound healing and scar-free healing would be valuable for both the equine and human (Carter et al., 2003).
As mentioned previously, equine distal limb wounds cannot be closed primarily and should be covered by dressing layers to control bacterial proliferation, stimulate re-epithelialization and contraction, and does not induce unwarranted antigenic reaction. In recent decade, researches demonstrate that biologic dressings can stimulate wound healing by providing and conserving a moist environment that is favorable for regeneration and migration of epithelial cells, acting as a bacterial barrier, and delaying exuberant granulation tissue formation. Interestingly, these biologic dressings can prompt a minor inflammatory response, which probably has favorable effects on wound healing (Gomez et al., 2004; Purna and Babu, 2000; May, 1991; Hunt, 1990).
Mesenchymal stromal cells (MSCs) are multipotent stromal progenitor cells that contribute to regenerative procedures by involving in the proliferative, inflammatory, homeostatic, and remodeling phases of tissue regeneration (Gnecchi et al., 2008; Aggarwal et al., 2005; Ono et al., 2004). It has been shown that MSCs and Adipose-derived stem cells (ASCs) can self-renew and could be able to proliferate and differentiate into various cell lineages or by a paracrine effect via the secretion of growth, anti-apoptotic and anti-inflammatory factors (Choudhery et al., 2013; Abumaree et al., 2012; Ryan et al., 2007). ASCs have the highest proliferation and differentiation potential, followed by MSCs derived from bone marrow and cartilage. ASCs can stimulate human dermal fibroblast proliferation and secretion by direct cell-to-cell contact (Peng et al., 2008; Kim et al., 2007). In equines, several researchers reported that isolation and characterization of stem cells could be possible by use of equine-specific tissues (e.g. bone marrow, adipose tissue, and umbilical cord blood) (de Mattos Carvalho et al., 2009; Arnhold et al., 2007; Lee et al., 2004).
Amniotic membrane (AM) has been used as a skin substitute for treatment purpose (Lo and Pope, 2009; Kesting et al., 2008). It is the innermost layer of the placenta, with unique properties like, promotes epidermal regeneration, wound protection, accelerates wound healing, anti-inflammatory and bacteriostatic effects, anti-fibrotic properties, reduced scarring, and analgesic effects (Elheneidy et al., 2016; Mohan et al., 2017). AM does not have blood and/or lymphatic vessels, and nerves, so it has low immunogenicity properties (Singh et al., 2004). Amniotic cells produce and release growth factors, which can help keratinocyte proliferation and differentiation like epidermal growth factor (EGF) and its receptor, vascular endothelial growth factor (VEGF), and tissue inhibitors of metalloproteinase 1 and 2 (TIMP-1 and -2) (nTyszkiewicz et al., 1999; Ramakrishnan and Jayaraman, 1997).
The aim of current study was to evaluate the adipose derived mesenchymal cells (ADMSCs) cultured on decellularized amniotic membrane (DAM) in wound healing of distal part of equine limb.
Materials and Methods
All procedures were approved by the Ethics Committee of Faculty of Veterinary Medicine, University of Tehran. All processes were carried out with due care for animal welfare.
Four healthy adult horses (two males and two females) in good general health weighing between 300-400 kg and aged 4-18 years were used in this study. There were no visible and/or palpable abnormalities of their metacarpal/metatarsal regions. Hoof care was done two weeks before the beginning of the study. Their diet consisted of alfalfa hay. Free choice commercial grain was fed as necessary to maintain body condition. Water and mineral salt were provided ad libitum.
Grouping: 3 wounds 2x3 cm were created on distal aspect regions of each limb of all 4 horse, then wounds of each horse were divided into 4 groups as the following:
1- Wounds treated with decellularized amniotic membrane and mesenchymal stem cells. (DAM/ADMSCs)
2- Wounds treated with decellularized amniotic membrane. (DAM)
3- Wounds treated with sulfadiazine ointment. (Sulfadiazine)
4- Wounds left with no treatment. (Control)
Isolation and cultivation of adipose derived mesenchymal stem cells: The region above the dorsal gluteal muscle, at the base of the tail, was chosen as the adipose tissue collection site due to the availability of the adipose tissue, the absence of large veins, and easy access. The horses were sedated by intravenous administration of 2% xylazine (1 mg/kg body weight). In addition, subcutaneous nerve block was performed with 2% lidocaine hydrochloride around the site to be incised. The surgical site was prepared appropriately for aseptic surgery. An approximately 10 cm incision was performed parallel to and approximately 15 cm below the spinal column, permitting visualization of a layer of adipose tissue between the skin and musculature. Approximately 5 g of adipose tissue was collected and stored in a sterile 50 mL centrifuge tube containing phosphate-buffered saline (PBS) solution plus 1% penicillin/ streptomycin. Then, the skin was sutured with nylon suture in simple interrupted sutures (Carvalho et al., 2009). Equine MSCs were obtained by enzymatic digestion with collagenase according to routine protocols. Briefly, the adipose tissue was washed several times with PBS solution containing 1% penicillin-streptomycin. Then the samples were placed in petri dishes to separate fibrous tissue and blood and dice them to approximately 0.2 to 0.3 cm size with a 15-scalpel blade and surgical forceps. Then they were placed in a solution of 0.04% type 1 collagenase at 37 °C, 5.0% CO2 for 45 min. After this period, the solution was filtered through a 150-micrometer filter to remove undigested tissue, followed by neutralization of the enzyme with DMEM (Dulbecco’s modified Eagle’s medium) containing 10% FBS, and then the solution was centrifuged twice at 400 × g for 15 min. The supernatant was aspirated and added to PBS and homogenized for next centrifugation. A sample of cells was stained with Trypan Blue and counted using a microscope-counting chamber. Cells were cultured at a density of approximately 10 × 103 cells/cm2 in 25-cm2 flasks containing the culture medium described previously at 37 °C in a humidified atmosphere containing 95% air and 5% CO2. The culture medium was changed every three days until a cell confluence of ≥80% was reached (Barberini et al., 2014).
Preparation of amniotic membrane: AM was obtained from bovine placenta freshly. The tissue was washed with PBS containing antibiotics (100 U/ml penicillin and 100 µg /ml streptomycin). Then it was stored at −20 °C immediately and after 12 h, it was thawed. AM was washed with PBS, cut into pieces and put into 0.5% Triton X-100 solution containing antibiotics. This was shaken at 4 °C overnight. Then the AM pieces were washed with PBS. Decellularity of AM was confirmed by histopathology. 20 x30 mm sheaths of decellular AM were placed into the cell culture medium for cell seeding.
Wound creation: Horses were sedated with xylazine hydrochloride (0.4 - 0.6 mg/kg B.W. via I.V. route). Each horse was then anesthetized with I.V. injection of a combination of ketamine hydrochloride (2.2 mg/kg B.W.) and xylazine (1.1 mg/kg B.W.), and maintained with isoflurane inhalation for 20 to 30 min during the surgical procedure of wound creation. The metacarpi/metatarsi region was clipped and cleaned with isopropyl alcohol soaked gauze. A sterile 2× 3 cm rectangular template was used to ensure consistent wound surface area. A standardized full-thickness skin wound was generated on the dorso-medial surface of each third metacarpal/metatarsal bone centered between the metacarpophalangeal and carpometacarpal joints or meta-tarsophalangeal and tarsometatarsal joints. Full-thickness skin incisions (n = 12 wounds/ horse) were created and then the dermis and subcutis were removed. For controlling hemorrhage, sterile non-adhesive pad and bandaged with gauze–coated cotton wool and an elastic bandage were used. All wounds remained bandaged throughout the study period according to wound management protocols of the hosting facility. The wounds were gently cleaned with sterile gauze soaked in isotonic saline solution and were re-bandaged twice a week. The horses were monitored at regular intervals during experimental period.
Wound measurements: Digital photographs of the wounds were obtained at day 0, 5, 15, and 30. A standardized ruler was included in each photograph for digital calibration of the photographs. Gross evaluation of wound healing was performed based on the percent of wound contraction (WC %), area of epithelialization (AE) (cm2), and wound area (WA) (cm2).
Wound Contraction was calculated using the formula:
(W0 – WI) / W0* 100
W0 = the initial wound measurement
WI = the wound measurement on day of measurement
Biopsy sampling: Biopsy samples were obtained on days 5, 15, and 30 of treatment. Horses were sedated before the procedures and the biopsy sites were cleaned with saline solution and gauze. Full-thickness biopsies with 2-3 mm margin of intact skin were taken. Samples were fixed in 10% neutral-buffered formalin, embedded in paraffin, sectioned at 5 μm thickness and stained with hematoxylin and eosin (H&E) and also Masson’s trichrome stain (MT) using standard procedures for light microscopy. Microscopic evaluation was performed by a pathologist. Epithelial hyperplasia, inflammation, granulation bed, angiogenesis, and fibroplasia were the evaluated criteria and grading was done according to Tracey et al. (2014).
Statistical analysis: Data was analyzed as a repeated measurement analysis of variance. Significance was set at P Value < 0.05.
Wound Geometric Analysis: Day 5: The mean ± SD of total wound area for each treatment group in day 5 was as follows: DAM/ADMSCs, 5.03 ± 0.55 cm2; DAM, 5.52 ± 0.20 cm2; Sulfadiazine, 4.99 ± 0.13 cm2; and Control, 5.55± 0.17 cm2. There were some significant differences among groups: Total wound area in day 5 in DAM/ADMSCs group was significantly less than in DAM group (P=0.046) and Control group (P=0.0370). In Sulfadiazine group there is a significantly lesser total wound area from DAM (P=0.034) and Control group (P=0.027). There was no significant difference between the size of wounds in groups DAM/ADMSCs and Sulfadiazine.
The mean ± SD of epithelialized area of each group in day 5 was as follows: DAM/ADMSCs, 0.22 ± 0.05 cm2; DAM, 0.17 ± 0.04 cm2; Sulfadiazine, 0.18 ± 0.05 cm2; and Control, 0.18± 0.02 cm2. There was not any significant difference between groups.
The mean ± SD of wound contraction percentage of each group in day 5 was as follows: DAM/AMSCs, 16.24 ± 2.11%; AM, 11.38 ± 1.50 %; Sulfadiazine, 12.75 ± 2.12 %; and Control 6.74 ± 2.66 %. Significant differences were determined between DAM/ADMSCs and group DAM (P=0.016), group Control (P=0.000). Wounds dressed only with DAM (P=026) and wounds treated with sulfadiazine (P=007) both showed better wound contraction compared with group Control. But any significant disagreement in wound contraction at day 5 was not shown between group DAM and Sulfadiazine.
Day 15: The mean ± SD of total wound area for each treatment group in day 15 was as follows: DAM/ADMSCs, 3.47 ± 0.25 cm2; DAM, 4.24 ± 0.14 cm2; Sulfadiazine, 3.50 ± 0.21 cm2; and Control, 4.60 ± 0.17 cm2. Significant differences between groups: wound size in DAM/ADMSCs group was significantly smaller than AM group (P= 0.009) and Control group (P=0.011). Similarly, wounds treated with Sulfadiazine show a significant decrease of size compared with DAM group (P= 0.023) and Control group (P=0.008).
The mean ± SD of epithelialized area for each treatment group in day 15 was as follows: DAM/ADMSCs, 0.31 ± 0.04 cm2; AM, 0.24 ± 0.02 cm2; Sulfadiazine, 0.22 ± 0.05 cm2; and Control, 0.23 ± 0.02 cm2. Significant differences revealed that group AM/MSCs had a wider area of epithelialization than groups Sulfadiazine (P= 0.020) and Control (P= 0.034).
The mean ± SD of wound contraction percentage of each group in day 15 was as follows: DAM/ADMSCs, 16.24 ± 2.11%; DAM, 13.27 ± 1.84 %; Sulfadiazine, 13.08 ± 2.83 %; and Control 11.09 ± 2.77 %. Wound contraction in group DAM/ADMSCs was significantly more than groups DAM (P=0.036), Sulfadiazine (P=0.030) and Control (P=0.006).
Day 30: The mean ± SD of wound size of each group in day 30 was: DAM/ADMSCs, 2.50 ± 0.06 cm2; DAM, 3.47 ± 0.07 cm2; Sulfadiazine, 3.29 ± 0.09 cm2; and Control, 3.91 ± 0.15 cm2. Statistical analysis showed significant differences in wound size of day 30 between all four groups (P<0.05), such that DAM/ADMSCs had the least wound size compared with the other groups. DAM wound area was greater than Control but had smaller wound area than Sulfadiazine group.
The mean ± SD of epithelialized area for each treatment group in day 30 was as follows: DAM/ADMSCs, 0.37 ± 0.06 cm2; DAM, 0.28 ± 0.02 cm2; Sulfadiazine, 0.30 ± 0.05 cm2; and Control, 0.26 ± 0.03 cm2. There was a significant difference between group DAM/ADMSCs and Control (P= 0.034) in epithelialization (Fig 3.).
The mean ± SD of wound contraction percentage of each group in day 30 was as follows: DAM/ADMSCs, 25.69 ± 2.15%; DAM, 18.02 ± 3.04 %; Sulfadiazine, 19.13 ± 2.98 %; and Control 14.45 ± 2.23 %. Wound contraction in group DAM/ADMSCs was significantly more than groups AM (P=0.036), Sulfadiazine (P=0.030) and Control (P=0.006). (Fig 3.)
Microscopic evaluation: At day 5, the most cases received DAM and/or DAM/ADMSCs, demonstrated focal and partial re-epithelization on the upper portion of the wound edges (Fig 4.a and b). No obvious re-epithelialization was seen in cases related to the control and sulfadiazine received-groups (4. c and d). An immature, edematous hyper granulation tissue with congested vessels and focal and/or diffuse hemorrhagic area were also seen in dermis of control and sulfadiazine-received groups. Newly organized collagen bundles were not prominent in all cases in these two groups. In cases that were applied by DAM, in dermis, an edematous and immature hyper granulation tissue with diffuse infiltration of inflammatory cells around newly blood vessels with irregular arrangement of moderate number of active fibroblasts, relatively prominent neo-angiogenesis, and slight collagen deposition were detected. In cases that were applied by DAM/ADMSCs, the immature granulation tissue with diffuse infiltration of inflammatory cell with the somewhat same severity was seen compared to previous group. Irregular arrangement of fibroblasts, and new capillary formation, congested vessels, and hemorrhage was also seen in dermal layer with less severity compared to the cases in group with DAM dressing. Fibroblast and few collagen perpendicular to new blood vessel and parallel to wound surface were occupied more in deep dermis. No adnexal re-formation was detected in all cases in this time point. Statistical analysis showed that the amount of re-epithelization in groups which received DAM and DAM/ADMSCs were more prominent compared to the control group (P= 0.001 and P= 0.005 respectively) and sulfadiazine-received group (P= 0.001 and P= 0.005 respectively). No significant differences were detected about the amount of inflammation, granulation bed, angiogenesis, and fibroplasia among different groups in this time point (P>0.05).
At day 15, in control group, the newly formed epithelium was partial and was confined to the edge of the wound in most cases. In dermis, an edematous granulation tissue with moderate presence of inflammatory cells particularly neutrophil and lesser amount of mononuclear cells existed (Fig 5.d). In group which received sulfadiazine, the surface was mainly covered by a layer made up of necrotic fibrinoid debris. The hyper granulation tissue was occupied by moderate to severe infiltration of polymorphonuclear cells, and large amount of neo-angiogenesis. Hemorrhage and vascular congestion were also detected in cases in this group (Fig 5.c). Better organization of fibroblasts compared to previous evaluated time point with less deposition of collagen was the other observed event. In cases that received DAM, in most cases partial re-epithelization, denuded area covered by scab and ulcer with bacterial colony were detected in superficial surface. New epithelialization covered about one-half of the wound surface. In dermal layer, edematous granulation tissue with inflammatory cell was noted with lower severity than previous time point. The granulation tissue became more mature in this time. Rich neo-vascularization was observed in the papillary layer (Fig 5.b). In addition, vascular congestion and even hemorrhage, and slight to moderate deposition of collagen fibers were detected in sub epidermal layer. In cases with DAM/ADMSCs treatment, the surface was mainly filled with necrotic debris and fibrin (crusts); however, re-epithelization was partially at margin (Fig 5.a). In sub epidermal layer, a highly vascularized and proliferating granulation tissue, consisting of more active fibroblasts, mild to moderate amount of collagen fibers, and immature capillaries was detected. The dermis showed mild edema in upper part. An organized hyper granulation tissue formation with moderate amounts of neutrophils, eosinophil, obvious perivascular inflammation, and also, noticeable vascular congestion that was more severe than previous time point but was lesser than cases in DAM group at same time point were detected. Statistical analysis demonstrated that the amount of fibroplasia in group that received DAM and DAM/ADMSCs was higher than group which received sulfadiazine (P= 0.01 and P= 0.01 respectively).
At day 30, in group that received DAM, microscopic examination revealed the formation of epithelial cells from the edge of skin which invade the area to cover it (Fig 6.b). Dermis cellularity increased mainly due to fibroblasts proliferation and new matrix deposition, also infiltration of inflammatory cells (commonly mononuclear leukocyte type). There was a reduction in the inflammatory process. Vascular granulation tissues dominated by fibroblasts and extensive collagen deposition. At this time point, sub-epithelial healing still continued in all wound sites. Hemorrhage, congestion, neo-vascularization and edema were other detected events in this group with lower severity than two other previous time points. The reticular dermis in the wound healing area had a connective tissue arrangement similar to the dense ordered with fibroblasts aligned in parallel. In control group, incomplete re-epithelization was detected in the margin of some cases. The severity of congestion, edema, and hemorrhage was mild (Fig 6.d). In Sulfadiazine received-group, the re-epithelization was still incomplete and was seen more in the margins. In dermis, relatively mature hyper granulation tissue with slight superficial edema was seen. The amount of neo-angiogenesis was decreased compared to previous time points. The main portion of dermis showed flabby connective tissue with moderately organized interconnecting collagen fibers running parallel to each (Fig 6.c). In group that received DAM/ADMSCs, in most cases, relatively partial epidermis reformation with moderate thickness in margin was detected. Edema below the epidermis with mild to moderate perivascular mononuclear inflammatory cell infiltrate and also eosinophil existed. Granulation tissue exhibited reduction in the number of vessels mainly in the deeper layers of the wound. Extracellular matrix showed predominance of thick collagen fibers, but still with poor organization (Fig 6.a). In some cases, it was seen that the fibrous collagenous scar tissue was so increased that it filled up the whole crater of the defects. The wound sites of these cases were devoid of the skin adnexa. In this time point, no significant differences were detected about the evaluated criteria among experimental groups (P>0.05).
The amniotic membrane is a suitable substance for scaffolding in soft tissue engineering. It is the inner layer of the placenta and consists of an epithelial layer, basement membrane and a stroma without vascular system. This unique structure and other biological and mechanical properties of the AM recommend it as a favorable wound dressing (Ian Göedert Leite Duarte et.al, 2014). AM has many properties such as antibacterial function, low antigenicity, availability and positive effects on cell proliferation and adhesion. The amniotic membrane has been widely applied as a soft tissue scaffold, especially for skin wounds and corneal lesions (Hassan Niknejad et.al, 2008). An ideal scaffold for skin tissue reconstruction requires a biocompatible surface to make a microenvironment for cell proliferation and adhesion. Decellularization of AM not only decreases the immunogenicity of this biological scaffold but also helps the exposure of its extracellular matrix biomolecules that promotes its characteristics (Ian Göedert Leite Duarte et.al, 2014).
ADMSCs are stem cells for autologous transplantation in cell therapy. Availability, great potential of differentiation into a variety of cells, as well as ordinary isolation and culture, have made ADMSCs a common source for cell therapies.
The purpose of our evaluation was to assess the possibility of use and efficacy of decellularized amniotic membrane seeded with autologous adipose derived-mesenchymal stem cells on wound healing of equine distal part of limb. The result of wound geometry demonstrates the appropriate performance of the DAM/ADMSCs in wound contraction, decrease of wound size and re-epithelialization compared with wounds treated with AM or sulfadiazine and no treated wounds. Histopathological findings showed significant differences: re-epithelization and fibroplasia of wounds covered by DAM/ADMSCs and DAM compared with control and sulfadiazine group.
These results indicate positive effects of using DAM to improve the quality and speed of wound healing. Use of DAM as a scaffold for ADMSCs showed better results. But it seems that the use of DAM/ADMSCs with topical antibiotics (such as sulfadiazine) to reduce the infection, as well as repeating the treatment during the healing process, can lead to better results.
The authors acknowledge the support from Institute of Biomedical Research at University of Tehran, as well as Department of pathology of Faculty of Veterinary Medicine for the histological experiments. Also, Mardabad Veterinary Research and Teaching hospital acknowledged for animal studies. The authors thank Mr.Shad for his assistance in the animal surgeries.
Conflicts of interest
The author declared no conflict of interest.